Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03100474 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:

StatusActive, Not Recruiting
PhaseNot specified
SponsorInSightec
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 2, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jun 2023 to Jun 2026 Completion date: Jan 2024 to Jun 2026v10 Show 1 more changeShow less
    • Completion date: Jan 2024 to Jun 2026
  2. Study sites: 8 to 9v9
  3. Primary completion date: Jan 2022 to Jun 2023v8
  4. Primary completion date: Jan 2021 to Jan 2022v7
  5. Primary completion date: Jan 2020 to Jan 2021v6
Show 4 earlier versionsHide 4 earlier versions
  1. Trial status: Recruiting to Active, Not Recruiting Site details revised at 8 of 8 sitesv5 Show 1 more changeShow less
    • Site details revised at 8 of 8 sites
  2. Site contacts updated at 1 of 8 sitesv4
  3. Study sites: 2 to 8v3
  4. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
InSightec
42 trials monitored
See 1 trial at risk
Parkinson's Disease
1,435 trials monitored
See 62 trials at risk
A global post approval study to collect safety and effectiveness data related to ExAblate Neuro for the treatment of certain disorders such as Essential Tremor, Parkinson's Movement Disorders, or Neuropathic Pain within the thalamus and/or pallidum.
Trial Details
NCT Number NCT03100474
Lead Sponsor InSightec
Conditions Essential Tremor, Parkinson's Disease, Movement Disorders, Neuropathic Pain
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov